BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24563500)

  • 21. [Testosterone therapy].
    Diemer T; Hauptmann A; Wagenlehner FM
    Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The aging male: testosterone deficiency and testosterone replacement. An up-date.
    Alexandersen P; Christiansen C
    Atherosclerosis; 2004 Apr; 173(2):157-69. PubMed ID: 15064089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late-onset hypogonadism.
    Bassil N
    Med Clin North Am; 2011 May; 95(3):507-23, x. PubMed ID: 21549875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related changes in testosterone and the role of replacement therapy in older men.
    Allan CA; McLachlan RI
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):653-70. PubMed ID: 15163327
    [No Abstract]   [Full Text] [Related]  

  • 26. Testosterone and cardiovascular risk in men.
    Kelly DM; Jones TH
    Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Andropause and testosterone deficiency: how to treat in 2012?].
    Renneboog B
    Rev Med Brux; 2012 Sep; 33(4):443-9. PubMed ID: 23091954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone, cardiovascular disease and the metabolic syndrome.
    Corona G; Rastrelli G; Vignozzi L; Mannucci E; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):337-53. PubMed ID: 21397202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone therapy: many players and much controversy.
    Sigman M
    Fertil Steril; 2015 May; 103(5):1144-5. PubMed ID: 25934600
    [No Abstract]   [Full Text] [Related]  

  • 31. Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes.
    Carruthers M; Cathcart P; Feneley MR
    Aging Male; 2015; 18(4):217-27. PubMed ID: 26218766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement therapy and cardiovascular risk factors modification.
    Chahla EJ; Hayek ME; Morley JE
    Aging Male; 2011 Jun; 14(2):83-90. PubMed ID: 21539436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
    Sigalos JT; Pastuszak AW; Khera M
    Med Clin North Am; 2018 Mar; 102(2):361-372. PubMed ID: 29406064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone and men's quality of life.
    Moncada I
    Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of testosterone on cardiovascular disease in men].
    Payer J; Banárová A
    Vnitr Lek; 2010 Jul; 56(7):702-8. PubMed ID: 20842916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.